Maria Nachury

Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial

Julián Panés, Damián García‐Olmo, Gert Van Assche et al. · The Lancet · 2016 · 1.1K citations

Medicine, Biotechnology, Cell Therapy +15

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

David Laharie, Arnaud Bourreille, Julien Branche et al. · The Lancet · 2012 · 642 citations

Pharmacy, Internal Medicine, Pharmacotherapy +14

Safety and Efficacy of Antigen-Specific Regulatory T-Cell Therapy for Patients With Refractory Crohn's Disease

Pierre Desreumaux, Arnaud Foussat, Matthieu Allez et al. · Gastroenterology · 2012 · 377 citations

Life Sciences, Immunology, Clinical Immunology +13

Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease

Lysiane Marthey, Christine Mateus, Charlotte Mussini et al. · Journal of Crohn s and Colitis · 2016 · 342 citations · Full text

Medicine, Immunology, Oncology +17

Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study

Yoram Bouhnik, Franck Carbonnel, David Laharie et al. · Gut · 2017 · 333 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +14